Hyundai Bioscience COVID-19 treatment candidate shows efficacy with dexamethasone
SEOUL– South Korean biotechnology firm Hyundai Bioscience Co. said Tuesday that the combination of its oral antiviral candidate and dexamethasone showed high efficacy in treating